is tirzepatide a glp-1 agonist Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data How does the simultaneous activation
Description
Various sources were referred to in the secondary research process to identify and collect information for this study
Handling & Use Conditions Allow the vial to equilibrate before opening

A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis

SURMOUNT-4 Investigators

Garcia-Perez L-E, Maldonado JM, Ranta KT, Raha S

Professor Receives Grant to Study Effectiveness of GLP-1 Weight-Loss Drugs Andrew Stokes, associate professor of global health, has received a grant from the Robert Wood Johnson Foundation to analyze the real-world effectiveness of this new class of therapies and inequities in access to these medications